Tag: Dantrium

Dantrium (dantrolene sodium) is a powerful muscle relaxant with a notable Black Box Warning regarding its potential for severe, and in some cases, fatal hepatotoxicity. This serious risk makes understanding **what are the contraindications for Dantrium** paramount before beginning therapy, especially for long-term use.

First introduced in 1967, dantrolene sodium, originally marketed under the brand name Dantrium, is a postsynaptic muscle relaxant used primarily to treat muscle spasticity. When asking, "What is another name for Dantrium?" the answer refers to its generic name, dantrolene, and other brands such as Revonto and Ryanodex.

The mortality rate for malignant hyperthermia plummeted from 70-80% to under 10% after the introduction of dantrolene sodium. In a medical emergency, knowing **what is the difference between Dantrium and RYANODEX**, two intravenous formulations of this critical drug, can be life-saving for patients susceptible to this rare and dangerous condition.

First synthesized in 1967, Dantrolene sodium was eventually commercialized under the brand name Dantrium. The question of who makes Dantrium has a complex answer involving several companies, as both branded and generic versions have come to market over the decades.